Integral Remediation for Major Depression ("Rehabilitación Integral Para la Depresión Mayor", RIDEM)

Sponsor
Hospital de Sant Pau (Other)
Overall Status
Unknown status
CT.gov ID
NCT03624621
Collaborator
Instituto de Salud Carlos III (Other)
90
1
3
33.6
2.7

Study Details

Study Description

Brief Summary

Available pharmacological and psychotherapeutic treatments are not effective for the treatment of cognitive symptoms of major depressive disorder (MDD). More recent studies have described that functional disability and the indirect costs of MDD (e.g., sick leaves at work, decreased productivity, ...) are related to persistent cognitive deficits. Some programs of cognitive rehabilitation and cognitive training (developed for other pathologies) have been tested, but the results are inconsistent.

There is an imperative need to develop a specific comprehensive rehabilitation program for MDD that includes the benefits of traditional functional remediation (FR) and computerized cognitive training (CCT) programs adjusted for each patient's cognitive deficit.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Functional Remediation
  • Device: Computerized Cognitive Training (CCT)
  • Behavioral: Psychoeducation
  • Device: Online games
N/A

Detailed Description

Objectives: To develop the Integral Rehabilitation Program (FR + CCT) and to demonstrate its efficacy in cognitive and functional remission (i.e. global remission) of patients with MDD in clinical remission.

Methodology: The project will consist of two stages:
    • Development and adaptation of the Integral Rehabilitation program for MD, based on the program developed for bipolar disorder, and including a computerized cognitive training adjusted to the neuropsychological profile of each patient;
    • A clinical trial, randomized, blind evaluator, with three intervention arms: INTEGRAL REHABILITATION (FR + CCT); PSYCHOEDUCATION + online games; and TREATMENT AS USUAL.

Sample size will be a total of 90 patients with MDD in remission (full or partial).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized single-blind and controlled clinical trialRandomized single-blind and controlled clinical trial
Masking:
Single (Outcomes Assessor)
Masking Description:
Codification of participants, assessor will never know what treatment arm participant was allocated
Primary Purpose:
Treatment
Official Title:
RIDEM Integral Remediation for Major Depression. Efficacy Study of a Functional Remediation Program and Cognitive Training
Actual Study Start Date :
Mar 15, 2018
Anticipated Primary Completion Date :
Oct 31, 2019
Anticipated Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Functional Remediation + CCT

12 sessions (1 per week) of group functional remediation program (90 min/session) plus 20 min of tailored computerized cognitive training (CCT)

Behavioral: Functional Remediation
Functional remediation includes directed group sessions tapping into the main cognitive domains affected in depression (executive functioning, attention and memory) as well as their implication in daily living.
Other Names:
  • Cognitive Remediation
  • Device: Computerized Cognitive Training (CCT)
    12 add-on sessions (20-minute long) after each group session to train cognitive domains.
    Other Names:
  • CogniFit (registered brand)
  • Placebo Comparator: Psychoeducation + Online Games

    12 sessions (1 per week) of psychoeducation for major depression (90 min/session) plus 20 min of playing freely with online games (pre-selected by investigators)

    Behavioral: Psychoeducation
    12 sessions of psychoeducation on depression, providing information about the disease, causes, consequences and other useful data for the management of depression.
    Other Names:
  • Group sessions
  • Device: Online games
    Participants play non-directed online games during 20 minutes after each psychoeducation grup session to make the two active intervention more similar.
    Other Names:
  • friv.com
  • No Intervention: Treatment as usual

    Usual intervention supervised by their psychiatrist

    Outcome Measures

    Primary Outcome Measures

    1. Change from baseline Functioning Assessment Short Test (FAST) score at 6 and 15 months [3 and 12 months after intervention]

      Assessment of daily functioning of depressed patients, including economics, cognition, social relationships, leisure and personal care

    Secondary Outcome Measures

    1. Change from baseline perceived cognitive deficits (PDQ) [3 and 12 months after intervention]

      Self-appraisal of cognitive functioning

    Other Outcome Measures

    1. Change from baseline cognitive functioning [baseline and 12 months after intervention]

      Objective neuropsychological battery to assess cognitive domains

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 and 60 years (males and females)

    • diagnosis of Major Depression (criteria Diagnostic and Statistical Manual 5th edition, DSM-5) in Remission or Partial Remission phase (scores below 14 in the Hamilton Depression Rating Scale-17 items (HDRS-17))

    • Cognitive Symptoms (-1.5SD (standar deviation) in objective as subjective tests),

    • PDQ > 20

    • FAST> 17

    Exclusion Criteria:
    • Intelligence Quotient (IQ) < 85

    • Any medical condition that may affect cognition

    • Presence of any comorbid psychiatric condition (including abuse or dependence on substances in the last three months)

    • Electroconvulsive therapy (ECT) in the previous year

    • Other psychological intervention in the 6 months prior to the study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital de la Santa Creu i Sant Pau Barcelona Catalonia Spain 08025

    Sponsors and Collaborators

    • Hospital de Sant Pau
    • Instituto de Salud Carlos III

    Investigators

    • Principal Investigator: Maria J Portella, Dr, IBB-Sant Pau

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Maria J Portella, Head of the Research Group in Psychiatric Disorders, Hospital de Sant Pau
    ClinicalTrials.gov Identifier:
    NCT03624621
    Other Study ID Numbers:
    • IIBSP-rid-2017-107
    First Posted:
    Aug 10, 2018
    Last Update Posted:
    Aug 24, 2018
    Last Verified:
    Aug 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Maria J Portella, Head of the Research Group in Psychiatric Disorders, Hospital de Sant Pau
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 24, 2018